D'ANGELO, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 2.598
AS - Asia 1.200
EU - Europa 848
SA - Sud America 127
Continente sconosciuto - Info sul continente non disponibili 115
AF - Africa 26
OC - Oceania 3
Totale 4.917
Nazione #
US - Stati Uniti d'America 2.507
SG - Singapore 488
IT - Italia 222
HK - Hong Kong 192
CN - Cina 187
RU - Federazione Russa 182
VN - Vietnam 133
BD - Bangladesh 108
FR - Francia 106
BR - Brasile 91
CA - Canada 68
DE - Germania 59
FI - Finlandia 54
GB - Regno Unito 52
NL - Olanda 36
SE - Svezia 33
IN - India 27
PL - Polonia 24
UA - Ucraina 21
JP - Giappone 17
AR - Argentina 16
ES - Italia 14
AT - Austria 13
IE - Irlanda 11
ZA - Sudafrica 11
MX - Messico 9
TR - Turchia 8
EC - Ecuador 7
IL - Israele 5
TH - Thailandia 5
BE - Belgio 4
CH - Svizzera 4
LT - Lituania 4
VE - Venezuela 4
AU - Australia 3
CL - Cile 3
CZ - Repubblica Ceca 3
EG - Egitto 3
IQ - Iraq 3
JM - Giamaica 3
MY - Malesia 3
PK - Pakistan 3
SC - Seychelles 3
SV - El Salvador 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
BO - Bolivia 2
GH - Ghana 2
GT - Guatemala 2
ID - Indonesia 2
KR - Corea 2
KZ - Kazakistan 2
MA - Marocco 2
PE - Perù 2
PH - Filippine 2
RO - Romania 2
TW - Taiwan 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
CR - Costa Rica 1
DZ - Algeria 1
EU - Europa 1
HN - Honduras 1
KE - Kenya 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MK - Macedonia 1
OM - Oman 1
QA - Qatar 1
SA - Arabia Saudita 1
SI - Slovenia 1
UZ - Uzbekistan 1
VC - Saint Vincent e Grenadine 1
YE - Yemen 1
Totale 4.803
Città #
San Jose 403
Council Bluffs 368
Ashburn 300
Hong Kong 191
Singapore 120
Dallas 105
Fairfield 97
Beijing 85
The Dalles 76
Kent 75
Moscow 69
Lauterbourg 68
Los Angeles 67
New York 64
Helsinki 50
Dong Ket 48
Chandler 43
Buffalo 42
Seattle 42
Jacksonville 38
Woodbridge 38
Wilmington 36
Toronto 32
Houston 31
Boardman 30
Santa Clara 30
Cambridge 29
Ho Chi Minh City 29
Warsaw 23
Hanoi 21
Boston 20
Chicago 20
Amsterdam 18
Montreal 18
Tokyo 17
Chennai 15
Frankfurt am Main 15
London 15
Milan 14
Orem 14
Rome 14
Brooklyn 12
Dublin 12
Phoenix 12
São Paulo 12
Johannesburg 11
Nuremberg 11
Princeton 11
Atlanta 10
Munich 10
Denver 9
Ann Arbor 8
Assago 8
Düsseldorf 8
Naples 8
Poplar 8
Porto Sant'elpidio 8
Tampa 8
Centro 7
Miami 7
Miano 7
Stockholm 7
Vico Equense 7
Montoro 6
San Diego 6
Ankara 5
Cancellara 5
Haiphong 5
Venice 5
Bangkok 4
Brussels 4
Camerino 4
Elk Grove Village 4
Falkenstein 4
Manchester 4
Mumbai 4
Salt Lake City 4
San Francisco 4
Shanghai 4
Sterling 4
Aprilia 3
Buenos Aires 3
Chiswick 3
City of London 3
Columbus 3
Da Nang 3
Fresno 3
Gustavo Adolfo Madero 3
Hangzhou 3
Hải Dương 3
Mexico City 3
Ogden 3
Ottawa 3
Philadelphia 3
Queens 3
Redondo Beach 3
San Salvador 3
Taranto 3
Tel Aviv 3
Turku 3
Totale 3.167
Nome #
From structure to function for the characterization of ERAP1 active site in Behçet syndrome. A novel polymorphism associated with known gene variations 191
Pistacia lentiscus Hydrosol: Untargeted Metabolomic Analysis and Anti-Inflammatory Activity Mediated by NF-κB and the Citrate Pathway 166
New Insights into Behçet's Syndrome Metabolic Reprogramming: Citrate Pathway Dysregulation 149
Correlation of Tumor Necrosis Factor-α −308G>A Polymorphism with Susceptibility, Clinical Manifestations, and Severity in Behçet Syndrome: Evidences from an Italian Genetic Case–Control Study 134
A First Step for the Molecular Characterization of Neurological Involvement of Behçet Syndrome: an Italian Pivotal Study 133
Distribution of rs17482078 and rs27044 ERAP1 polymorphisms in a group of Italian Behçet’s syndrome patients: a preliminary case–control study 116
Genotyping of Italian patients with Behçet syndrome identified two novel ERAP1 polymorphisms using sequencing-based approach 105
Distribution of rs17482078 and rs27044 ERAP1 polymorphisms in a group of Italian Behçet’s syndrome patients: a preliminary case–control study 103
ERAP1 molecular characterization: Identification of a de novo allelic variant 93
Identification of a de novo NLRP3 gene variation in an Italian Behçet syndrome patient 93
TNFα rs1800629 Polymorphism and Response to Anti-TNFα Treatment in Behçet Syndrome: Data from an Italian Cohort Study 89
Biologic therapy and spinal radiographic progression in patients with axial spondyloarthritis: A structured literature review 86
Assessing vitamin D levels in an anti-DFS70 positive population: New insights emerging 85
An Italian Disease-Based Registry of Axial and Peripheral Spondyloarthritis: The SIRENA Study 82
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 78
Harmonization of ANA testing challenge: quantification strategy to accurately predict end-point titers avoiding serial dilution 77
Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis 77
Corticosteroid injection treatment for dactylitis in psoriatic arthritis 77
Clinical phenotypes of Behçet’s syndrome in a large cohort of Italian patients: focus on gender differences 75
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 73
UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract (GIT) 2.0 Reflux Scale Correlates With Impaired Esophageal Scintigraphy Findings in Systemic Sclerosis 73
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 73
Genotyping of Italian patients with Behçet syndrome identified two novel ERAP1 polymorphisms using sequencing-based approach 73
Early Spondyloarthritis Clinic: Organizational Improvements in the Patient Journey 72
Axial Spondyloarthritis: Reshape the Future—From the “2022 GISEA International Symposium” 71
Assessment of Patient–Physician Interactions in Psoriatic Arthritis: National Results of the ASSIST Study 70
Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study 69
Ankylosing Spondylitis - Axial Spondyloarthritis (2nd ed.) 66
Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life study 63
Broad clinical spectrum of SARS-CoV-2-associated inflammatory joint disease in adults: a report of 35 cases from the COVID-19 & Autoimmune Systemic Disease Italian study group 63
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 62
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus 62
An international multicentre analysis of current prescribing practices and shared decision-making in psoriatic arthritis 61
Adherence to therapy in people with rheumatic and musculoskeletal diseases in Italy and the role of the digital health: results of an expert Delphi consensus survey 60
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 57
Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis 55
Quality of life and therapeutic management of axial spondyloarthritis patients in Italy: a 12-month prospective observational study 55
Improvement of Function and Its Determinants in a Group of Axial Spondyloarthritis Patients Treated with TNF Inhibitors: A Real-Life Study 53
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of the scleroderma spectrum 51
Management of Dactylitis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations 51
Prevalence of Type 2 and Type 1 Diabetes in Psoriatic Arthritis 51
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus 51
Serum amyloid A in healthy subjects: assessment of reference value using ELISA method 51
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 51
Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial 50
How do patient-reported outcome measures affect treatment intensification and patient satisfaction in the management of psoriatic arthritis? A cross sectional study of 503 patients 49
Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: a report of 66 cases 49
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case–control study from the Italian national multicenter “SPRING” (Systemic Sclerosis Progression InvestiGation) Registry 48
Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEA 48
Morphologic, dynamic and high-resolution microscopy MRI in early-onset spondyloarthritis finger dactylitis 46
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus 46
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 46
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry ‘SPRING’ of the Italian Society for Rheumatology 46
Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study 45
Incidence, prevalence and mortality of systemic sclerosis in Italy: a nationwide population-based study using administrative health data 44
The role of adalimumab in the treatment of heart block in HLA-B27-associated disease: a case description 44
Management of psoriatic arthritis: a consensus opinion by expert rheumatologists 43
Residual Disease in Patients with Axial Spondyloarthritis: A Post-Hoc Analysis of the QUASAR Study 43
The Italian Society for Rheumatology recommendations for the management of axial spondyloarthritis 42
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 39
Understanding the Biological Significance of Anti-DFS70 Antibodies: Effect of Biologic Therapies on Their Occurrence in Inflammatory Arthritis 38
Impact of the COVID-19 Pandemic on the Appropriateness of Diagnostic Pathways of Autoimmune Rheumatic Diseases 38
The relationship between HLA-B*51 subtypes, clinical manifestations and severity of Behçet’s syndrome: a large Italian cohort study 38
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort 38
Reply to the letter to the editor: Dynamic contrast-enhanced MRI could assess the local disease activity of enthesitis and dactylitis in patients with spondyloarthritis 37
More than a random association between chronic obstructive pulmonary disease and psoriatic arthritis: shared pathogenic features and implications for treatment 34
Retrospective evaluation of patient profiling and effectiveness of apremilast in an Italian multicentric cohort of psoriatic arthritis patients 34
Toxicological considerations in the treatment of axial spondylo-arthritis 33
The Conundrum of Psoriatic Arthritis: a Pathogenetic and Clinical Pattern at the Midpoint of Autoinflammation and Autoimmunity 33
Real-world effectiveness of golimumab in the treatment of patients with active rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis who failed initial TNF-α inhibitor therapy: a pooled analysis of European prospective observational studie 31
IL-23 in axial spondyloarthritis and psoriatic arthritis: a good fit for biological treatment? 31
Real‐world effectiveness and persistence of golimumab as second‐line anti‐TNFα drug in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis patients in Italy: GO‐BEYOND, a 12‐month prospective observational study 29
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 28
Paradoxical psoriatic arthritis in a patient with psoriasis treated with guselkumab 27
Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases 25
First-line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING-SIR registry 19
The clinical profile of systemic sclerosis without a ‘scleroderma pattern’ at nailfold capillaroscopy: results from the multicenter SPRING registry of the Italian Society of Rheumatology 14
Clinical and serological features of triple autoantibody-negative patients with systemic sclerosis: insights from the multicentric SPRING registry of the Italian Society for Rheumatology 12
Results of an expert Delphi consensus from the Italian Society of Medical and Interventional Radiology (SIRM) and the Italian Society of Rheumatology (SIR) on standardized requesting and reporting magnetic resonance imaging in patients with suspected or known axial spondyloarthritis 12
Interstitial lung involvement in rheumatoid arthritis patients treated with abatacept: a prospective observational study 10
Mycophenolate Mofetil Treatment Reduces the Risk of Treatment Escalation Due to Vascular Complications in Limited Cutaneous Systemic Sclerosis: Emulation of a Target Trial From the Italian Rheumatology Society SPRING Registry 10
Age and onset timing of Raynaud’s phenomenon and first non-Raynaud symptom as prognostic factors in systemic sclerosis: a retrospective analysis from the Italian national multicenter Systemic Sclerosis Progression INvestiGation registry of the Italian Society for Rheumatology (SPRING-SIR) 9
Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults 8
Prevalence, distribution and associations of the scleroderma capillaroscopic patterns: new insights from the Italian SPRING-SIR registry 7
Pulmonary Arterial Hypertension Incidence in Patients With Systemic Sclerosis Treated With Bosentan for Digital Ulcers: Evidence From the SPRING-SIR Registry 7
Ultrasound for assessing disease activity and structural damage in psoriatic arthritis: the UPsA scores from a multicentre study by the Italian Society of Rheumatology 6
When one joint matters: the monoarticular blind spot in inflammatory arthritis 6
Pregnancy and Behçet Syndrome: A Large Retrospective Italian Study 6
Non-steroidal anti-inflammatory drugs in psoriatic arthritis: clinical practice suggestions based on scientific evidence and expert opinion 6
Elderly-onset systemic sclerosis defines a distinct clinical subset: analysis from the SPRING registry of the Italian Society for Rheumatology 5
Menopause in systemic sclerosis: the impact on clinical presentation in a multicenter cross-sectional analysis from the National Registry of the Italian Society for Rheumatology (SPRING-SIR) 5
The Impact of Sex on the Pattern and Clinical Response of Early Psoriatic Arthritis: Real-life Data from the Italian Prospective SIRENA Study 4
Prevalence and clinical relevance of digital ulcers in systemic sclerosis patients from the real-life: the experience of the SPRING Registry of the Italian Society for Rheumatology 3
Totale 4.917
Categoria #
all - tutte 26.886
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.886


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022126 0 15 28 18 7 5 13 7 10 4 0 19
2022/2023114 15 0 2 3 13 18 0 15 32 3 12 1
2023/202480 7 7 5 3 5 14 3 4 10 0 0 22
2024/20251.015 5 2 29 148 88 31 159 70 220 35 120 108
2025/20262.844 109 147 108 311 281 295 496 110 178 312 382 115
2026/2027332 227 105 0 0 0 0 0 0 0 0 0 0
Totale 4.917